Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Sunitinib in Muscle-Invasive Bladder Cancer
NCT00526656Phase 2Completed
- Sponsor
- Case Comprehensive Cancer Center
- Start
- Sep 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in bladder cancer, sponsored by Case Comprehensive Cancer Center. Started Sep 2007; status: completed.
02
Drugs
sunitinib
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00526656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00526656.